How many insider trades does FilingIQ track for SVRA?

FilingIQ tracks 267 Form 4 insider transactions for SVRA (Savara Inc), covering filings from Apr 27, 2017 onwards. 20 of those were filed in the last 90 days.

Are SVRA insiders net buyers or net sellers?

Across the full Form 4 history for SVRA, 110 transactions (41%) were open-market purchases and 34 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SVRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SVRA in?

Savara Inc (SVRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.18B.

SVRA insider trading

NasdaqGS Healthcare

Savara Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

267

Last 90 days

Buys / sells

41% / 13%

Market cap

$1.18B

About Savara Inc

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Company website: www.savarapharma.com

SVRA insider activity at a glance

FilingIQ has scored 267 insider transactions for SVRA since Apr 27, 2017. The most recent filing in our index is dated Mar 18, 2026.

Across the full history, 110 open-market purchases and 34 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SVRA insider trades is 55.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SVRA trades on FilingIQ Raw filings on SEC EDGAR

Latest SVRA Form 4 filings

Lowrance David L Chief Financial Officer

S Dec 16, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding SVRA

Nantahala Capital Management, LLC

$20.88M · 1.2% of AUM

Frequently asked

How many insider trades does FilingIQ track for SVRA?: FilingIQ tracks 267 Form 4 insider transactions for SVRA (Savara Inc), covering filings from Apr 27, 2017 onwards. 20 of those were filed in the last 90 days.
Are SVRA insiders net buyers or net sellers?: Across the full Form 4 history for SVRA, 110 transactions (41%) were open-market purchases and 34 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SVRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SVRA in?: Savara Inc (SVRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.18B.

Methodology & sources

Every SVRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.